New drugs for the treatment of attention-deficit/hyperactivity disorder

Author： Pataki Caroly S Feinberg David T McGough James J

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.9, Iss.2, 2004-11, pp. : 293-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New drugs for treatment of attention-deficit/hyperactivity disorder

By Chung Bowen Suzuki Alejandra R McGough James J

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 269-276

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for attention-deficit/hyperactivity disorder

By Weisler Richard H

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 3, 2007-09 ,pp. : 423-434

Informa Healthcare

Access to resources Recommend Favorite

Do adrenergically active drugs have a role in the first-line treatment of attention-deficit/hyperactivity disorder?

By Hazell Philip

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 1989-1998

Informa Healthcare

Access to resources Recommend Favorite

Modafinil: A Treatment Alternative for Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Child and Adolescent Psychopharmacology News, Vol. 7, Iss. 6, 2002-12 ,pp. : 5-7

Guilford Publications Inc

Access to resources Recommend Favorite

Neutraceuticals and Diet Restriction for the Treatment of Attention-Deficit/Hyperactivity Disorder

Child and Adolescent Psychopharmacology News, Vol. 17, Iss. 5, 2012-10 ,pp. : 5-12

Guilford Publications Inc

Access to resources Recommend Favorite